![](https://investorshub.advfn.com/uicon/675751.png?cb=1586875012)
Thursday, December 09, 2021 10:56:43 AM
Press Release | 12/09/2021
On December 3, 2021, Plandai Biotechnology, Inc. executed a settlement agreement and release of claims with legacy creditor Berkshire Capital Management Co., Inc.
Pursuant to the terms of the settlement, in exchange for a mutual release of all claims, Berkshire agreed to release Plandai from any and all obligations to pay principal and accrued interest under unsecured promissory notes totaling principal of $6,900,000.
Tad Mailander, Plandai's interim CEO, commented: "I am pleased to have resolved these legacy debts in favor of the Company and its shareholders. Removing this material debt from the Company's balance sheet will positively impact future plans, as it advances all of the company's current financial priorities focused on reducing debt and improving financial flexibility."
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM